World Solve

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.

Diagnosing Alzheimer's currently often requires expensive brain imaging or invasive procedures, limiting how widely early detection can be used. A cheap, accessible blood test could change how early treatment can begin.

COPD gradually reduces lung function over years, and while treatment can ease symptoms and slow decline, it can't reverse the underlying lung damage. A cure remains out of reach for the millions living with this condition.

Age-related macular degeneration is a leading cause of vision loss in older adults, and current treatments can slow progression in some cases but rarely restore lost vision. A true reversal treatment remains undeveloped.

Even when people successfully lose significant weight, the body's biology often works to regain it over time, undermining long-term success. Understanding and countering this biological pushback remains a major open challenge.

Chronic pelvic pain often has no clearly identifiable cause even after extensive testing, leaving many patients with limited treatment options. A deeper understanding of its underlying causes remains needed.

Cervical cancer remains highly preventable through regular screening, but many women in lower-resource regions lack consistent access to the tests that catch it early. Closing this access gap could prevent large numbers of otherwise preventable deaths.

Many people with chronic insomnia end up relying on sleep medication for years, since non-drug treatments don't work consistently for everyone. A more effective, sustainable solution remains an open need.

Some life-saving medications, including certain antibiotics and chemotherapy drugs, carry a risk of permanent hearing damage as a side effect. A way to protect hearing during necessary treatment remains undeveloped.

Even with modern reproductive technology, a significant share of infertility cases have no clear cause and don't respond well to existing treatments. Understanding these unexplained cases remains a major gap in reproductive medicine.

Patients on dialysis often endure hours of treatment multiple times a week indefinitely, significantly affecting their quality of life. A better long-term solution, beyond transplant, remains an unmet need.

Diabetes can lead to serious complications like blindness, kidney failure, or amputation, but predicting which patients are most at risk early enough to intervene remains imprecise. Better prediction could allow more targeted, effective prevention.

Effective vaccines exist for a small number of sexually transmitted infections, but many common ones still have no vaccine available at all. Expanding vaccine coverage here could significantly reduce global disease burden.

This gut infection frequently returns after treatment, partly because antibiotics disrupt the broader gut microbiome that would normally help prevent it. Better prevention of recurrence remains an unresolved clinical challenge.

People with celiac disease must avoid gluten completely for life, since no treatment currently exists to let them safely consume it again. A real treatment or cure would free patients from this lifelong dietary restriction.

Even mild traumatic brain injuries can cause lasting cognitive effects that current treatments struggle to fully reverse. A better understanding of brain recovery mechanisms could open new treatment paths.

A significant share of patients with depression don't respond adequately to standard treatments, and doctors currently have limited ability to predict who will respond to which approach. Better personalized treatment matching remains an open challenge.

Lower back pain is one of the most common causes of disability worldwide, yet treatment for chronic cases still mostly focuses on symptom management rather than fixing underlying structural or nerve issues. A more definitive solution remains elusive.

Glaucoma often causes irreversible vision loss before it's diagnosed, since early stages typically have no noticeable symptoms. Better early detection and prevention methods remain a pressing unmet need in eye care.

Chronic sinus inflammation affects a large number of people and current treatments, from medication to surgery, often only partially resolve symptoms long-term. A more definitive treatment remains undeveloped.